165 related articles for article (PubMed ID: 31870962)
1. Poloxamer 407 based-nanoparticles for controlled release of methotrexate.
Moura S; Noro J; Cerqueira P; Silva C; Cavaco-Paulo A; Loureiro A
Int J Pharm; 2020 Feb; 575():118924. PubMed ID: 31870962
[TBL] [Abstract][Full Text] [Related]
2. A micelle-like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery.
Ren J; Fang Z; Yao L; Dahmani FZ; Yin L; Zhou J; Yao J
Int J Pharm; 2015 Jun; 487(1-2):177-86. PubMed ID: 25865570
[TBL] [Abstract][Full Text] [Related]
3. PTS micelles for the delivery of hydrophobic methotrexate.
Cerqueira P; Noro J; Moura S; Guimarães D; Silva C; Cavaco-Paulo A; Loureiro A
Int J Pharm; 2019 Jul; 566():282-290. PubMed ID: 31128212
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
Butt AM; Mohd Amin MC; Katas H
Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
[TBL] [Abstract][Full Text] [Related]
6. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
Zhao J; Zhao M; Yu C; Zhang X; Liu J; Cheng X; Lee RJ; Sun F; Teng L; Li Y
Int J Nanomedicine; 2017; 12():6735-6746. PubMed ID: 28932117
[TBL] [Abstract][Full Text] [Related]
8. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
9. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
Katiyar SS; Kushwah V; Dora CP; Jain S
Int J Pharm; 2019 Feb; 557():86-96. PubMed ID: 30584909
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
13. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
Sharma M; Malik R; Verma A; Dwivedi P; Banoth GS; Pandey N; Sarkar J; Mishra PR; Dwivedi AK
J Biomed Nanotechnol; 2013 Jan; 9(1):96-106. PubMed ID: 23627072
[TBL] [Abstract][Full Text] [Related]
14. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide.
Soni G; Yadav KS
Pharm Dev Technol; 2014 Sep; 19(6):651-61. PubMed ID: 23879721
[TBL] [Abstract][Full Text] [Related]
15. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
16. Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery.
Jang JH; Jeong SH; Lee YB
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284483
[TBL] [Abstract][Full Text] [Related]
17. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH
PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled poloxamer-legumin/vicilin nanoparticles for the nanoencapsulation and controlled release of folic acid.
Fang C; Kanemaru K; Carvalho WSP; Fruehauf KR; Zhang S; Das PP; Xu C; Lu Y; Rajagopalan N; Kulka M; Makeiff DA; Serpe MJ
Int J Biol Macromol; 2024 May; 268(Pt 2):131646. PubMed ID: 38636765
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
